ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

AACR 2017

AACR 2017

Dual HER2 blockade with trastuzumab and lapatinib yielded good response rates in HER2-amplified, RAS wild type, treatment-refractory metastatic colorectal cancer patients, according to results of the HERACLES study.

This video examines current research on the use of vaccines in low-grade glioma for the prevention of high-grade disease.

This video examines a study that used liquid biopsies to monitor disease progression in patients with bladder cancer.

This video reviews the latest trials and research on immunotherapeutic agents being tested in breast cancer.

A nivolumab/ipilimumab combination significantly improved overall survival for advanced melanoma patients.

This video highlights a novel scoring system using microRNA signatures that predicted poor overall survival and bone metastasis in patients with luminal A breast cancer.

This video examines how a specific combination of KIR/KIR-ligand genotypes in high-risk neuroblastoma patients may be predictive of outcomes when adding dinutuximab to isotretinoin.

Pages

Subscribe to AACR 2017 on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.